 Eric Hink
Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Orbit | 7 | 2024 | 70 | 1.650 |
Why?
| | Eyelids | 7 | 2024 | 37 | 1.650 |
Why?
| | Eyelid Diseases | 5 | 2024 | 19 | 1.610 |
Why?
| | Orbital Cellulitis | 4 | 2025 | 17 | 1.270 |
Why?
| | Orbital Fractures | 4 | 2017 | 9 | 1.080 |
Why?
| | Surgical Mesh | 1 | 2024 | 47 | 0.840 |
Why?
| | Titanium | 1 | 2024 | 82 | 0.810 |
Why?
| | Tetralogy of Fallot | 1 | 2024 | 79 | 0.810 |
Why?
| | Oculomotor Muscles | 3 | 2017 | 40 | 0.770 |
Why?
| | Sarcoma, Kaposi | 1 | 2022 | 81 | 0.740 |
Why?
| | Population Surveillance | 1 | 2025 | 482 | 0.730 |
Why?
| | Eye Infections, Bacterial | 4 | 2015 | 28 | 0.720 |
Why?
| | Ophthalmologic Surgical Procedures | 7 | 2015 | 58 | 0.700 |
Why?
| | Eye Infections, Fungal | 3 | 2017 | 7 | 0.670 |
Why?
| | Orbital Diseases | 2 | 2017 | 32 | 0.660 |
Why?
| | Skull Neoplasms | 1 | 2017 | 23 | 0.540 |
Why?
| | Sphenoid Bone | 1 | 2017 | 17 | 0.540 |
Why?
| | Down Syndrome | 1 | 2024 | 496 | 0.530 |
Why?
| | Meningioma | 1 | 2017 | 91 | 0.490 |
Why?
| | Blepharophimosis | 1 | 2013 | 3 | 0.420 |
Why?
| | Candidiasis | 1 | 2013 | 56 | 0.410 |
Why?
| | Eye Injuries | 2 | 2014 | 45 | 0.390 |
Why?
| | Prostheses and Implants | 3 | 2024 | 143 | 0.380 |
Why?
| | Conjunctiva | 1 | 2011 | 51 | 0.350 |
Why?
| | Surgical Wound Infection | 1 | 2013 | 307 | 0.320 |
Why?
| | Golf | 1 | 2008 | 7 | 0.300 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2013 | 363 | 0.290 |
Why?
| | Child, Preschool | 11 | 2025 | 11074 | 0.290 |
Why?
| | Tomography, X-Ray Computed | 9 | 2017 | 2691 | 0.270 |
Why?
| | Inflammation | 1 | 2017 | 2837 | 0.240 |
Why?
| | Humans | 32 | 2025 | 137585 | 0.230 |
Why?
| | Adolescent | 14 | 2025 | 21513 | 0.220 |
Why?
| | Age Distribution | 1 | 2025 | 392 | 0.220 |
Why?
| | Sex Distribution | 1 | 2025 | 375 | 0.220 |
Why?
| | Alprostadil | 1 | 2024 | 32 | 0.220 |
Why?
| | Orbital Neoplasms | 3 | 2015 | 24 | 0.210 |
Why?
| | Retrospective Studies | 11 | 2025 | 15657 | 0.210 |
Why?
| | Infant | 7 | 2025 | 9465 | 0.210 |
Why?
| | Surgical Flaps | 3 | 2015 | 130 | 0.200 |
Why?
| | Child | 12 | 2025 | 21935 | 0.200 |
Why?
| | Syndrome | 1 | 2024 | 358 | 0.200 |
Why?
| | Eye Burns | 1 | 2022 | 12 | 0.200 |
Why?
| | Compartment Syndromes | 1 | 2022 | 25 | 0.190 |
Why?
| | Dacryocystorhinostomy | 2 | 2015 | 10 | 0.190 |
Why?
| | Optic Nerve | 1 | 2022 | 64 | 0.190 |
Why?
| | Eye | 1 | 2022 | 108 | 0.180 |
Why?
| | Injections | 1 | 2022 | 183 | 0.180 |
Why?
| | Male | 17 | 2025 | 67762 | 0.180 |
Why?
| | Mucormycosis | 2 | 2017 | 22 | 0.160 |
Why?
| | Incidence | 2 | 2025 | 2804 | 0.160 |
Why?
| | Cicatrix | 2 | 2017 | 64 | 0.160 |
Why?
| | Eye Pain | 2 | 2017 | 7 | 0.150 |
Why?
| | Female | 18 | 2025 | 73304 | 0.140 |
Why?
| | Neoplasm Invasiveness | 2 | 2017 | 510 | 0.140 |
Why?
| | Mucocele | 1 | 2017 | 12 | 0.140 |
Why?
| | Mucorales | 1 | 2017 | 1 | 0.140 |
Why?
| | Paranasal Sinus Diseases | 1 | 2017 | 15 | 0.140 |
Why?
| | Nose Diseases | 1 | 2017 | 13 | 0.130 |
Why?
| | Graves Ophthalmopathy | 1 | 2017 | 10 | 0.130 |
Why?
| | Conjunctival Diseases | 1 | 2017 | 18 | 0.130 |
Why?
| | Floods | 1 | 2017 | 17 | 0.130 |
Why?
| | Amnion | 1 | 2017 | 28 | 0.130 |
Why?
| | Receptor, IGF Type 1 | 1 | 2017 | 65 | 0.130 |
Why?
| | Soft Tissue Injuries | 1 | 2017 | 33 | 0.130 |
Why?
| | Corneal Diseases | 1 | 2017 | 35 | 0.130 |
Why?
| | Critical Care | 1 | 2022 | 601 | 0.130 |
Why?
| | Stevens-Johnson Syndrome | 1 | 2017 | 39 | 0.130 |
Why?
| | Colorado | 2 | 2025 | 4565 | 0.130 |
Why?
| | Visual Acuity | 4 | 2017 | 356 | 0.130 |
Why?
| | Craniotomy | 1 | 2017 | 77 | 0.130 |
Why?
| | Endoscopy | 2 | 2017 | 318 | 0.130 |
Why?
| | Infant, Newborn | 3 | 2025 | 6079 | 0.120 |
Why?
| | Diagnosis, Differential | 3 | 2017 | 1483 | 0.120 |
Why?
| | Vision Disorders | 1 | 2017 | 142 | 0.120 |
Why?
| | Streptococcal Infections | 3 | 2015 | 151 | 0.120 |
Why?
| | Disasters | 1 | 2017 | 98 | 0.120 |
Why?
| | Cavernous Sinus Thrombosis | 1 | 2015 | 9 | 0.120 |
Why?
| | Lacrimal Apparatus | 1 | 2015 | 9 | 0.120 |
Why?
| | Lacrimal Duct Obstruction | 1 | 2015 | 7 | 0.120 |
Why?
| | Polyglycolic Acid | 1 | 2015 | 43 | 0.120 |
Why?
| | Absorbable Implants | 1 | 2015 | 35 | 0.120 |
Why?
| | Immunologic Factors | 1 | 2017 | 236 | 0.110 |
Why?
| | Biopsy | 2 | 2017 | 1129 | 0.110 |
Why?
| | Prednisone | 1 | 2015 | 240 | 0.110 |
Why?
| | ACTH-Secreting Pituitary Adenoma | 1 | 2014 | 11 | 0.110 |
Why?
| | Osteotomy | 1 | 2015 | 119 | 0.110 |
Why?
| | Facial Paralysis | 1 | 2014 | 22 | 0.110 |
Why?
| | Exophthalmos | 2 | 2017 | 18 | 0.110 |
Why?
| | Follow-Up Studies | 4 | 2014 | 5131 | 0.110 |
Why?
| | Platinum | 1 | 2014 | 50 | 0.100 |
Why?
| | Mycobacterium chelonae | 1 | 2013 | 9 | 0.100 |
Why?
| | School Admission Criteria | 1 | 2013 | 27 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 5 | 2017 | 3566 | 0.100 |
Why?
| | Lactic Acid | 1 | 2015 | 305 | 0.100 |
Why?
| | Silicone Elastomers | 1 | 2013 | 7 | 0.100 |
Why?
| | Jaw Fractures | 1 | 2013 | 2 | 0.100 |
Why?
| | Adult | 10 | 2022 | 37929 | 0.100 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2015 | 198 | 0.100 |
Why?
| | Facial Bones | 1 | 2013 | 30 | 0.100 |
Why?
| | Surgery, Plastic | 1 | 2013 | 45 | 0.100 |
Why?
| | Bites and Stings | 1 | 2013 | 32 | 0.100 |
Why?
| | C-Reactive Protein | 1 | 2015 | 410 | 0.100 |
Why?
| | Skull Fractures | 1 | 2013 | 36 | 0.100 |
Why?
| | Analgesics | 1 | 2015 | 206 | 0.100 |
Why?
| | Eye Injuries, Penetrating | 1 | 2013 | 19 | 0.100 |
Why?
| | Gold | 1 | 2014 | 118 | 0.100 |
Why?
| | Sinusitis | 1 | 2015 | 221 | 0.100 |
Why?
| | Eye Foreign Bodies | 1 | 2013 | 25 | 0.100 |
Why?
| | Ophthalmology | 1 | 2013 | 86 | 0.100 |
Why?
| | Suture Techniques | 1 | 2013 | 122 | 0.100 |
Why?
| | Pain, Postoperative | 1 | 2015 | 265 | 0.100 |
Why?
| | Aged, 80 and over | 6 | 2015 | 7635 | 0.090 |
Why?
| | Craniocerebral Trauma | 1 | 2014 | 170 | 0.090 |
Why?
| | Dogs | 1 | 2013 | 413 | 0.090 |
Why?
| | Adenoma | 1 | 2014 | 230 | 0.090 |
Why?
| | Middle Aged | 9 | 2017 | 33479 | 0.090 |
Why?
| | Glucocorticoids | 1 | 2015 | 594 | 0.090 |
Why?
| | Fracture Fixation, Internal | 1 | 2013 | 188 | 0.080 |
Why?
| | Retinal Neoplasms | 1 | 2010 | 25 | 0.080 |
Why?
| | Endophthalmitis | 1 | 2010 | 29 | 0.080 |
Why?
| | Retinoblastoma | 1 | 2010 | 32 | 0.080 |
Why?
| | Antibodies, Monoclonal | 1 | 2017 | 1430 | 0.080 |
Why?
| | Intraoperative Complications | 1 | 2011 | 138 | 0.080 |
Why?
| | Fellowships and Scholarships | 1 | 2013 | 306 | 0.080 |
Why?
| | Streptococcus agalactiae | 1 | 2010 | 93 | 0.080 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2010 | 137 | 0.080 |
Why?
| | Education, Medical, Graduate | 1 | 2013 | 486 | 0.080 |
Why?
| | Blindness | 1 | 2008 | 38 | 0.070 |
Why?
| | Burkitt Lymphoma | 1 | 2008 | 60 | 0.070 |
Why?
| | Aged | 7 | 2017 | 23961 | 0.070 |
Why?
| | Decision Making | 1 | 2014 | 900 | 0.070 |
Why?
| | Age Factors | 1 | 2014 | 3295 | 0.060 |
Why?
| | Sweat Gland Neoplasms | 1 | 2006 | 6 | 0.060 |
Why?
| | Eyelid Neoplasms | 1 | 2006 | 10 | 0.060 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 2006 | 80 | 0.060 |
Why?
| | Biomarkers | 1 | 2015 | 4149 | 0.050 |
Why?
| | Treatment Outcome | 3 | 2017 | 10811 | 0.050 |
Why?
| | Postoperative Complications | 2 | 2013 | 2654 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2017 | 1993 | 0.040 |
Why?
| | Staphylococcal Infections | 2 | 2015 | 400 | 0.040 |
Why?
| | Intraocular Pressure | 1 | 2022 | 307 | 0.040 |
Why?
| | Anti-Bacterial Agents | 3 | 2015 | 1809 | 0.040 |
Why?
| | Young Adult | 2 | 2017 | 13209 | 0.040 |
Why?
| | Prospective Studies | 3 | 2015 | 7604 | 0.040 |
Why?
| | Diplopia | 1 | 2017 | 19 | 0.030 |
Why?
| | Intention to Treat Analysis | 1 | 2017 | 73 | 0.030 |
Why?
| | Ocular Motility Disorders | 1 | 2017 | 27 | 0.030 |
Why?
| | Decompression, Surgical | 1 | 2017 | 106 | 0.030 |
Why?
| | Nasolacrimal Duct | 1 | 2015 | 8 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2017 | 202 | 0.030 |
Why?
| | Diabetes Complications | 1 | 2017 | 227 | 0.030 |
Why?
| | Pregabalin | 1 | 2015 | 9 | 0.030 |
Why?
| | Blepharoplasty | 1 | 2015 | 10 | 0.030 |
Why?
| | Bone Nails | 1 | 2015 | 62 | 0.030 |
Why?
| | Perioperative Period | 1 | 2015 | 56 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2017 | 347 | 0.030 |
Why?
| | Venous Thrombosis | 1 | 2015 | 190 | 0.030 |
Why?
| | Administration, Oral | 1 | 2015 | 816 | 0.020 |
Why?
| | Pain Measurement | 1 | 2015 | 521 | 0.020 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 234 | 0.020 |
Why?
| | ROC Curve | 1 | 2014 | 554 | 0.020 |
Why?
| | Logistic Models | 1 | 2017 | 2074 | 0.020 |
Why?
| | Pain Management | 1 | 2015 | 352 | 0.020 |
Why?
| | Foreign Bodies | 1 | 2013 | 104 | 0.020 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2017 | 804 | 0.020 |
Why?
| | Microscopy, Acoustic | 1 | 2010 | 8 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1316 | 0.020 |
Why?
| | Eye Enucleation | 1 | 2010 | 12 | 0.020 |
Why?
| | Athletic Injuries | 1 | 2017 | 529 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2013 | 1236 | 0.020 |
Why?
| | Length of Stay | 1 | 2015 | 1215 | 0.020 |
Why?
| | Etoposide | 1 | 2008 | 158 | 0.020 |
Why?
| | Maxilla | 1 | 2007 | 38 | 0.020 |
Why?
| | Cyclophosphamide | 1 | 2008 | 247 | 0.020 |
Why?
| | Methotrexate | 1 | 2008 | 260 | 0.020 |
Why?
| | Doxorubicin | 1 | 2008 | 362 | 0.020 |
Why?
| | Mohs Surgery | 1 | 2006 | 27 | 0.020 |
Why?
| | Prognosis | 1 | 2014 | 4030 | 0.010 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2006 | 220 | 0.010 |
Why?
| | Quality of Life | 1 | 2017 | 2892 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2013 | 5778 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 1692 | 0.010 |
Why?
| | United States | 1 | 2013 | 14841 | 0.010 |
Why?
| | Animals | 1 | 2013 | 36940 | 0.010 |
Why?
|
|
Hink's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|